Mostrar el registro sencillo del ítem

dc.contributor.authorMartin-Odoom, Alexander
dc.contributor.authorAdiku, Theophilus
dc.contributor.authorDelgado, Elena 
dc.contributor.authorLartey, Margaret
dc.contributor.authorAmpofo, William Kwabena
dc.date.accessioned2019-04-12T11:25:26Z
dc.date.available2019-04-12T11:25:26Z
dc.date.issued2017-03
dc.identifier.citationGhana Med J. 2017 Mar;51(1):20-23.es_ES
dc.identifier.issn0016-9560es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7456
dc.description.abstractBACKGROUND: Access to antiretroviral therapy in Ghana has been scaled up across the country over the last decade. This study sought to determine the occurrence of transmitted HIV-1 drug resistance in pregnant HIV-1 positive women yet to initiate antiretroviral therapy at selected HIV Care Centres in Ghana. METHODS: Plasma specimens from twenty-six (26) HIV seropositive pregnant women who were less than 28weeks pregnant with their first pregnancy and ART naïve were collected from selected HIV care centres in three (3) regions in Ghana. Genotypic testing was done for the reverse transcriptase gene and the sequences generated were analyzed for HIV-1 drug resistance mutations using the Stanford University HIV Drug Resistance Database. RESULTS: Resistance mutations associated with the reverse transcriptase gene were detected in 4 (15.4%) of the participants. At least one major drug resistance mutation in the reverse transcriptase gene was found in 3 (11.5%) of the women. CONCLUSION: The detection of transmitted HIV-1 drug resistance in this drug-naïve group in two regional HIV care sites is an indication of the need for renewed action in monitoring the emergence of transmitted HIV-1 drug resistance in Ghana. FUNDING: None declared.es_ES
dc.description.sponsorshipNone declaredes_ES
dc.language.isoenges_ES
dc.publisherGhana Medical Associationes_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAntiretroviral therapyes_ES
dc.subjectDrug resistancees_ES
dc.subjectEmergencees_ES
dc.subjectMutationses_ES
dc.subject.meshAnti-HIV Agents es_ES
dc.subject.meshCross-Sectional Studies es_ES
dc.subject.meshDrug Resistance, Viral es_ES
dc.subject.meshFemale es_ES
dc.subject.meshGhana es_ES
dc.subject.meshHIV Infections es_ES
dc.subject.meshHIV-1 es_ES
dc.subject.meshHumans es_ES
dc.subject.meshInfectious Disease Transmission, Verticales_ES
dc.subject.meshMutation es_ES
dc.subject.meshPregnancy es_ES
dc.subject.meshPregnancy Complications, Infectious es_ES
dc.titleOccurrence of transmitted HIV-1 drug resistance among Drug-naïve pregnant women in selected HIV-care centres in Ghanaes_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución- 4.0 Internacional*
dc.identifier.pubmedID28959068es_ES
dc.format.volume51es_ES
dc.format.number1es_ES
dc.format.page20-23es_ES
dc.description.peerreviewedes_ES
dc.relation.publisherversionhttps://doi.org/10.4314/gmj.v51i1.4es_ES
dc.identifier.journalGhana medical journales_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución- 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución- 4.0 Internacional